Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer
Clinical trial NCT00856830 · COMPLETED
Trial details
- NCT number
- NCT00856830
- Sponsor
- University of Alabama at Birmingham
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2015-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.